Akebia Therapeutics Inc.

06/30/2022 | Press release | Distributed by Public on 06/30/2022 14:13

Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements[...]